Chung You Jung, Lee Chang Heon, Lim Jinyeong, Jang Jinhyeong, Kang Hyuno, Park Chan Beum
Department of Materials Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291, Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea.
Gwangju Center, Korea Basic Science Institute (KBSI), 77 Yongbong-ro, Buk-Gu, Gwangju 61186, Republic of Korea.
ACS Nano. 2020 Dec 22;14(12):16973-16983. doi: 10.1021/acsnano.0c06078. Epub 2020 Nov 25.
Extracellular deposition of β-amyloid (Aβ) peptide aggregates is a major characteristic of Alzheimer's disease (AD) brain. Because Aβ peptide aggregates aggravate neuropathy and cognitive impairment for AD patients, numerous efforts have been devoted to suppressing Aβ self-assembly as a prospective AD treatment option. Here, we report Aβ-targeting, red-light-responsive carbon dots (CDs), and their therapeutic functions as a light-powered nanomodulator to spatiotemporally suppress toxic Aβ aggregation both and . Our aptamer-functionalized carbon dots (Apta@CDs) showed strong targeting ability toward Aβ species. Moreover, red LED irradiation induced Apta@CDs to irreversibly denature Aβ peptides, impeding the formation of β-sheet-rich Aβ aggregates and attenuating Aβ-associated cytotoxicity. Consequently, Apta@CDs-mediated photomodualtion modality achieved effective suppression of Aβ aggregation , which significantly reduced the Aβ burden at the targeted sites in the brain of 5xFAD mice by ∼40% and ∼25% according to imaging and ELISA analyses, respectively. Our work demonstrates the therapeutic potential of photomodulating CDs for light-driven suppression against Aβ self-assembly and related neurotoxicity.
β-淀粉样蛋白(Aβ)肽聚集体的细胞外沉积是阿尔茨海默病(AD)大脑的主要特征。由于Aβ肽聚集体会加重AD患者的神经病变和认知障碍,人们已经做出了大量努力来抑制Aβ的自组装,将其作为一种潜在的AD治疗选择。在此,我们报告了靶向Aβ的红光响应性碳点(CDs)及其作为光驱动纳米调节剂的治疗功能,以时空抑制有毒Aβ聚集体。我们的适配体功能化碳点(Apta@CDs)对Aβ物种表现出强大的靶向能力。此外,红色发光二极管照射会诱导Apta@CDs使Aβ肽不可逆地变性,阻碍富含β-折叠的Aβ聚集体的形成,并减弱与Aβ相关的细胞毒性。因此,Apta@CDs介导的光调制方式实现了对Aβ聚集的有效抑制,根据成像和酶联免疫吸附测定分析,这分别使5xFAD小鼠大脑中靶向部位的Aβ负担显著降低了约40%和约25%。我们的工作证明了光调制碳点在光驱动抑制Aβ自组装及相关神经毒性方面的治疗潜力。